The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Berezhnaya S.V.

Kazan, Municipal health care «City hospital №6»

Iakupov É.Z.

Kafedra nevrologii, neĭrokhirurgii i meditsinskoĭ genetiki Kazanskogo gosudarstvennogo meditsinskogo universiteta

Zaharov Yu.A.

Institut of Physics of Kazan Volga Region Federal University, Kazan, Russia

The efficacy of combination therapy with mexidol and cerebrolysin in chronic cerebral ischemia

Authors:

Berezhnaya S.V., Iakupov É.Z., Zaharov Yu.A.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(5): 23‑27

DOI: 10.17116/jnevro20161165123-27

Read: 61090 times

Download PDF (RU)
Contact the author
Table of contents

THE EFFICACY OF COMBINATION THERAPY WITH MEXIDOL AND CEREBROLYSIN IN CHRONIC CEREBRAL ISCHEMIA
THE EFFICACY OF COMBINATION THERAPY WITH MEXIDOL AND CEREBROLYSIN IN CHRONIC CEREBRAL ISCHEMIA

To cite this article:

Berezhnaya SV, Iakupov ÉZ, Zaharov YuA. The efficacy of combination therapy with mexidol and cerebrolysin in chronic cerebral ischemia. S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(5):23‑27. (In Russ.)
https://doi.org/10.17116/jnevro20161165123-27

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
The effect of Mexi­dol on the level of neurogenesis markers in acute cere­brovascular acci­dent in the expe­riment. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):107-112
Cere­brolysin and the opti­mal timing of anti­coagulation resu­mption in stroke: combined post hoc survival analysis of the CERE­HETIS trial. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3-2):77-93
Personal characteristics of patients with cere­bral microangiopathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):51-56
Modern approaches to diagnosis and treatment of postinfectious asthenic syndrome in children. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):42-52
The main mechanisms of deve­lopment of cognitive impairment. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):13-18
The known and new ideas about the mechanism of action and the spectrum of effe­cts of Mexi­dol. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):22-33
Expe­rience of using reamberin for correction of cognitive status in patients with chro­nic cere­bral ischemia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):84-88
Quantitative and qualitative asse­ssment of the complete blood count in patients with obstructive sleep apnea and chro­nic ischemia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):95-102
Cere­brolysin with repe­rfusion therapy in ischemic stroke: a prospective analysis of multimodal brain imaging data from the CERE­HETIS trial. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):84-98
The impact of Mexi­dol on improving quality of life para­meters and functional kidney status as part of complex therapy for cognitive impairments in como­rbid patients with microalbuminuria against the background of arte­rial hype­rtension and type 2 diabetes mellitus. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(4):478-478
Abstract:

Objective. To study the impact of combination therapy with mexidol and cerebrolysin on the clinical status of patients with chronic cerebral ischemia (CCI), II stage, in ambulatory conditions. Material and methods. The study included 36 patients with CCI, II stage. In addition to basic therapy, patients received two courses of the mexidol/cerebrolysin combination during 6 weeks with 3 month-interval between the courses. The dynamics of subjective complaints of the patients and objective clinical signs was assessed after each course. The content of 13 chemical elements in the hair was determined by atomic-emission method after the treatment. Results and сonclusion/ Based on the results of clinical and neurological study, the efficacy of combination therapy with mexidol and cerebrolysin as long-term neuroprotection drugs was shown which manifested a significant reduction in the severity of all major symptoms under the influence of the therapy.

Keywords:

chronic cerebral ischemia
mexidol
cerebrolysin
microelement balance

Authors:

Berezhnaya S.V.

Kazan, Municipal health care «City hospital №6»

Iakupov É.Z.

Kafedra nevrologii, neĭrokhirurgii i meditsinskoĭ genetiki Kazanskogo gosudarstvennogo meditsinskogo universiteta

Zaharov Yu.A.

Institut of Physics of Kazan Volga Region Federal University, Kazan, Russia

Close metadata

References:

  1. Putilina MV. Sovremennye predstavlenija o terapii trevozhno-depressivnyh rasstrojstv pri hronicheskoj ishemii golovnogo mozga. Russkij medicinskij zhurnal. 2011;9:569-573. (In Russ.).
  2. Levin OS. Primenenie jekstrakta Ginkgo biloba (EGb 761) dlja lechenija kognitivnyh narushenij pri discirkuljatornoj jencefalopatii. Russkij medicinskij zhurnal. 2009;17(20):1356-1361. (In Russ.).
  3. Gromova OA. Nejrotroficheskaja sistema mozga: nejropeptidy, makro- i mikrojelemeny, nejrotroficheskie preparaty. Mezhdunarodnyj nevrologicheskij zhurnal. 2007;2(12):94-107. (In Russ.).
  4. Gogoleva IV. Vlijanie organicheskih solej litija, magnija, selena na jelementnyj gomeostaz golovnogo mozga na fone dvustoronnej hronicheskoj okkljuzii obshhih sonnyh arterij: Dis. … kand. med. nauk. M. 2009. Dostupno po: http://rsmu.ru/fileadmin/rsmu/documents/science/uchenii_sovet/news_2009_september/gogoleva_autoreferat.doc. Ssylka aktivna na 18.12.15. (In Russ.).
  5. Silina EV, Rumjanceva SA, Orlova AS. Narushenie pamjati i astenija. M.: Taktik-Studio; 2015. (In Russ.).
  6. Skoromec AA, Mel'nikova EV, Golikova RV, Amelin AV, Vavilov TV, Kadinskaja MI. Racional'nyj podhod k sosudistoj terapii hronicheskoj nedostatochnosti mozgovogo krovoobrashhenija. Atmosfera. Nervnye bolezni. 2005;1:29-31. (In Russ.).
  7. Smirnova IN, Fedorova TN, Tanashjan MM, Suslina ZA. Klinichekaja jeffektivnost' i antioksidantnaja aktivnost' meksidola pri hronicheskih cerbrovaskuljarnyh zabolevanijah. Atmosfera. Nervnye bolezni. 2006;1:33-36.(In Russ.).
  8. Nechipurenko NI, Veres AI, Vasilevskaja LA, Pashkovskaja ID. Mikrojelementnye i mikrodemodinamicheskie narushenija u pacientov s discirkuljatornoj jencefalopatiej pri ispol'zovanii Meksidola v kompleksnom lechenii. Nevrologija i nejrohirurgija v Belarusi. 2011;1(9):224-229. (In Russ.).
  9. Gromova OA, Torshin IJu, Gogoleva IV. Mehanizmy nejrotroficheskogo i nejroprotektornogo dejstvija preparata cerebrolizin pri ishemii golovnogo mozga. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2014;114:3(2):43-50. (In Russ.).
  10. Guseva MR. Nejropeptidnaja terapija pri atrofii zritel'nogo nerva u detej. Zhurnal nevrologi i psihiatrii im. S.S. Korsakova. 2010;4:37-40. (In Russ.).
  11. Gromova OA, Skal'nyj AV, Panasenko OM. Strukturnyj analiz i fermentativnaja antiokislitel'naja aktivnost' nejrometabolicheskih prepartov prirodnogo proishozhdenija: ceebrolizina, cerebrolizata, bilibila i aktovegina. Mikrojelementy v medicine. 2001;2:23-27. (In Russ.).
  12. Torshin IJu, Gromova OA. Mul'timodal'nyj jeffekt cerebrolizina protiv voinstvujushhego redukcionizma. Nevrologicheskij vestnik. 2008;XL(3):83-91. (In Russ.).
  13. Belova AN. Shkaly, testy i oprosniki v nevrologii i nejrohirurgii. M.: Samarskij dom pechati; 2004. (In Russ.).
  14. Kogan OG, Shmidt IR, Zaslavskij ES, Petrov BG, Bezborodova VA, Bobrovnikova TI. Metodicheskie rekomendacii dlja vrachej-kursantov. Novokuzneck; 1981. (In Russ.).
  15. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression scale. Acta Psychiat Scand. 1983;67:361-370.
  16. Berezhnaja SV, Jakupov JeZ, Zaharov Ju A. Izmenenija soderzhanija himicheskih jelementov v volosah bol'nyh hronicheskoj ishemiej golovnogo mozga. Zemskij vrach. 2013;19(2):29-33. (In Russ.).
  17. Skal'nyj AV. Referentnye znachenija koncentracii himicheskih jelementov v volosah, poluchennye metodom ISP-AJeS (ANO Centr bioticheskoj mediciny). Mikrojelementy v medicine. 2003;4(1):55-56. (In Russ.).
  18. Skal'nyj AV, Rudakov IA. Biojelementy v medicine. M.: ONIKS XX vek; Mir; 2004. (In Russ.).
  19. Sidorenko EV. Metody matematicheskoj obrabotki v psihologii. SPb.: OOO «Rech'»; 2007. (In Russ.).
  20. Sinjachenko OV, Stefanenko EP, Petrova VN, Piklun VL, Meshherjakova AV, Alferov VV. Soderzhanie makro- i mikrojelementov v volosah zdorovyh ljudej. Vestnik gigieny i jepidemiologii. 2007;11(1):120-126. (In Russ.).
  21. Gusev EI. Skvorcova VI. Ishemija golovnogo mozga. M.: Medicina; 2001. (In Russ.).
  22. Ding EL, Mozaffarian D. Optimal dietary habits for the prevention of stroke. Semin Neurol. 2006;26(1):11-23.  doi: 10.1055/s-2006-933305.
  23. Sajt «Centra bioticheskoj mediciny». Dostupno po: http://www.microelements.ru/poleznaja-informatsija/o-mikroelementakh/321/. Ssylka aktivna na 18.12.15. (In Russ.).
  24. Golubkina NA, Korchina TJa, Merkulova NN, Pestin SA, Taslickij SS. Selenovyj status Hanty-Mansijskogo avtonomnogo okruga (Surgut). Mikrojelemeny v medicine. 2005;6(1):2-8. (In Russ.).
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.